(1) If a physician provides an abortion-inducing drug to another for the purpose of inducing an abortion as authorized in Section 41-41-107: The physician shall report that action to the department; and
(2) If the physician knows that the woman who uses the abortion-inducing drug for the purpose of inducing an abortion experiences, during or after the use, an adverse event, the physician shall provide a written report of the serious event to the FDA via the Medwatch Reporting System.
(3) For the purposes of this section, “adverse event” shall be defined according to the FDA criteria given in the Medwatch Reporting System.